JavaScript NENÍ povolen !

Prosím povolte JavaScript.

* Zobrazit nápovědu

Nejvíce citované: 22760778

1 citací v PubMed Filtry

Nejvíce citovaný článek - PubMed ID 22760778

Záznam nenalezen v Medvik. Navštivte PubMed 22760778

Článek

The EHA Research Roadmap: Malignant Lymphoid Diseases

Dreyling, Martin
Autor Dreyling, Martin Department of Medicine III, LMU Hospital, Munich, Germany
André, Marc
Autor André, Marc Université Catholique de Louvain, CHU UcL Namur, Yvoir, Belgium
Gökbuget, Nicola
Autor Gökbuget, Nicola Department of Medicine II, Hematology/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany
Tilly, Hervé
Autor Tilly, Hervé INSERM U1245, Department of Hematology, Centre Henri Becquerel and Université de Rouen, France
Jerkeman, Mats
Autor Jerkeman, Mats Skåne University and Lund University, Lund, Sweden
Gribben, John
Autor Gribben, John Barts Cancer Institute, Queen Mary University of London, United Kingdom
Ferreri, Andrés
Autor Ferreri, Andrés Lymphoma Unit, Department of Onco-hematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
Morel, Pierre
Autor Morel, Pierre Service Hematologie Clinique Therapie Cellulaire, CHU Amiens Picardie, Amiens, France
Stilgenbauer, Stephan
Autor Stilgenbauer, Stephan Comprehensive Cancer Center Ulm (CCCU), Sektion CLL Klinik für Innere Medizin III, Universität Ulm, Germany
Fox, Christopher
Autor Fox, Christopher School of Medicine, University of Nottingham, United Kingdom

HemaSphere. 2022 Jun ; 6 (6) : e726. [epub] 20220519

Hemasphere
ISSN 2572-9241
Zdroj

Publikační typ
časopisecké články MeSH